StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
TD Cowen on Establishment Labs Inc. (ESTA): 'The Selloff Looks Overdone as a Major FDA Catalyst Approaches'
October 15, 2026 9:25 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $117.00 price target on Establishment Labs Inc. (NASDAQ: ESTA).The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments